2006
DOI: 10.1186/1471-2334-6-91
|View full text |Cite
|
Sign up to set email alerts
|

Soluble egg antigen of Schistosoma Haematobiuminduces HCV replication in PBMC from patients with chronic HCV infection

Abstract: Background: This study was conducted to examine, in vitro , the effect of soluble egg antigen (SEA) of S. haematobium on intracellular HCV RNA load in peripheral mononuclear cells (PBMC) as well as on cell proliferation in patients with chronic HCV infection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
18
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 33 publications
3
18
0
Order By: Relevance
“…2A, C, and E). These dose response data are comparable to those reported for studies of SEA stimulation of professional immune cells (28)(29)(30)(31) and informed our selection of an SEA dose of 25 g/ml for 24 h.…”
Section: Resultssupporting
confidence: 73%
“…2A, C, and E). These dose response data are comparable to those reported for studies of SEA stimulation of professional immune cells (28)(29)(30)(31) and informed our selection of an SEA dose of 25 g/ml for 24 h.…”
Section: Resultssupporting
confidence: 73%
“…This result reflects the diagnostic value of such antibodies to detect active viral infection and agrees with previous reports on susceptibility of cells from lymphatic origin to HCV infection and their support of virus replication [22][23][39][40][41][42][43].…”
Section: Discussionsupporting
confidence: 81%
“…Due to restricted availability of primary hepatocytes, the immortalized human hepatoma cell line HepG2 was later successfully used to host HCV replication in vitro [19][20][21]. In addition, several reports demonstrated replication and assembly of HCV-genotype 4 in peripheral blood mononuclear cells (PBMCs) from Egyptian infected patients [22][23]. Herein we confirmed successful HCV propagation in both human hepatoblastoma and blood cells.…”
Section: Introductionsupporting
confidence: 65%
“…Methods used for these assays were: (a) nested RT-PCR [10] including amplification of the highly conserved 5'-UTR sequences with nested primers in two rounds of amplification, including RT-PCR beads (Amersham Biosciences, Pittsburg, USA) in the first round, 0.2 mmol/L from each dNTP, two units of Taq DNA polymerase in the second round; (b) quantitative test of HCV RNA using C Amplicore, HCV monitor test Roche with broad dynamic range of 615 to 7,700,000 IU/mL (Amplicore, Reading, UK); and (c) HCV genotyping [11] including nested PCR amplification of HCV core gene using genotype specific primers in two rounds of amplification with 0.2 mmol/L from each dNTP and two units of Taq DNA polymerase.…”
Section: Hcv Rna Testsmentioning
confidence: 99%